✦ LIBER ✦

Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder

✍ Scribed by Thomas G. Salopeka; Sarvesh Logsettyb; Edward E. Tredgetb

Book ID: 117845559
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 484 KB
Volume: 47
Category: Article
ISSN: 1097-6787
DOI: 10.1067/mjd.2002.126273

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-CD20 monoclonal antibody (rituximab

Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus

✍ M.J. Arin; A. Engert; T. Krieg; N. Hunzelmann 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

Rituximab: A monoclonal antibody to CD20

Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris

✍ Abdul Kader El Tal; Marshall R. Posner; Zachary Spigelman; A. Razzaque Ahmed 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Anti-CD20 Monoclonal Antibody (Rituximab

Anti-CD20 Monoclonal Antibody (Rituximab) for the Treatment of Recurrent Idiopathic Membranous Nephropathy in a Renal Transplant Patient

✍ L. Gallon; D. Chhabra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

Data presented at the 49th Annual Meetin

Data presented at the 49th Annual Meeting of the American Society of Hematology held in Atlanta, Georgia in December 2007, has demonstrated dramatic positive results for the treatment of advanced follicular lymphoma with a single infusion of a combined anti-CD20 monoclonal antibody and a radioisotope.

✍ Rhonda Siddall 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) ⚖ 282 KB